Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PLX compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
PLX
Protalix BioTherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
PLX
Protalix BioTherapeutics, Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PLX, solid
AMGN, dashed
PLX
Protalix BioTherapeutics, Inc.
Change
2.52
▼
−6.51%
Mkt cap
$216.7M
Revenue
$20M
Q2 FY26
Revenue
$53M
FY25
AMGN
Amgen Inc
Change
462.66
▼
−3.31%
Regular session
Nov 5 '26
Mkt cap
$258.8B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
vs
Compare
Regular session
Nov 5 '26
PLX
Protalix BioTherapeutics, Inc.
vs
AMGN
Amgen Inc
2.52
▼
−6.51%
Price
462.66
▼
−3.31%
$216.7M
Mkt cap
$258.8B
Q2 FY26
$20M
Revenue
$10.4B
Q3 FY26
FY25
$53M
Revenue
$36.8B
FY25
Change
Change
PLX
2.52
▼
−6.51%
vs
AMGN
462.66
▼
−3.31%
Regular session
Nov 5 '26